Through the new DTP platform, Novartis will make Cosentyx available to patients at a price that reflects the average savings typically retained by insurers and pharmacy benefit managers
The platform is being introduced to expand access to treatments for people living with chronic conditions
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Drug Hunter is already relied upon by researchers at more than 200 leading organizations, including Eli Lilly, Biogen, Merck KGaA, Isomorphic Labs, Deerfield Management
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
Agreement further expands Aptar Pharma’s leading position in nasal delivery solutions and addresses significant unmet needs of delivering drugs locally over extended periods
Replicate will receive research funding and could potentially receive up to approximately US$550 million
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
Subscribe To Our Newsletter & Stay Updated
